Group | HADS A total mean (SD) | Propensity score matched (average treatment effects) coefficient (95% CI) | HADS A mean NDBO versus other P value | HADS A normal % (n) | HADS A borderline % (n) | HADS A positive % (n) | HADS A category NDBO versus other P value |
NDBO | 5.5 (4.5) | 69.0% (209) | 15.2% (46) | 15.8% (48) | |||
DBO | 4.7 (3.6) | −0.48 (−2.245 to 1.285) | 0.594 | 83.7% (41) | 8.2% (4) | 8.2% (4) | 0.125 |
GORD | 6.6 (5.0) | −0.433 (−1.53 to 0.665) | 0.44 | 64.1% (84) | 13.7% (18) | 22.1% (29) | 0.301 |
Colonic polyp | 4.7 (3.9) | 0.805 (−0.123 to 1.733) | 0.089 | 75.7% (112) | 12.8% (19) | 11.5% (17) | 0.329 |
Healthy | 2.8 (2.9) | 4.317 (3.589 to 5.045) | <0.001* | 93.8% (45) | 2.1% (1) | 4.2% (2) | 0.001* |
DBO, dysplastic Barrett’s oesophagus; GORD, gastro-oesophageal reflux disease; HADS, Hospital Anxiety and Depression Score; NDBO, non-dysplastic Barrett’s oesophagus.